Beck Depression Inventory
Also known as: BDI, BDI-II
The Beck Depression Inventory (BDI) is a 21-item self-report instrument designed to measure the severity of depressive symptoms in adolescents and adults. Developed by Aaron T. Beck in 1961 and revised as the BDI-II in 1996, it has become one of the most widely used screening and monitoring tools in clinical psychology and psychiatry.
Key highlights
- High sensitivity and specificity for detecting moderate to severe depression
- Brief administration time (5–10 minutes) suitable for clinical workflow
- Extensive validation across diverse clinical and non-clinical populations
- Useful for monitoring symptom change and treatment response over time
- Strong psychometric properties with Cronbach's alpha typically > 0.85
Intuition
This section is available to Pro members. Upgrade to Pro
How it works
This section is available to Pro members. Upgrade to Pro
When to use it
The BDI is appropriate for initial screening in primary care, mental health clinics, and research settings. It is especially useful for establishing a baseline severity level, monitoring treatment response, and detecting changes in depressive symptoms over time. Clinicians should avoid relying solely on BDI scores for diagnosis; it must be combined with clinical interview and structured assessment. The tool is less reliable in populations with severe cognitive impairment or active suicidality requiring immediate intervention.
Strengths & limitations
- High sensitivity and specificity for detecting moderate to severe depression
- Brief administration time (5–10 minutes) suitable for clinical workflow
- Extensive validation across diverse clinical and non-clinical populations
- Useful for monitoring symptom change and treatment response over time
- Strong psychometric properties with Cronbach's alpha typically > 0.85
- Self-report format vulnerable to response bias, social desirability, and insight limitations
- Somatic items (sleep, appetite) may overlap with medical conditions unrelated to depression
- Not a diagnostic instrument; cannot be used in isolation to confirm depression diagnosis
- Elevated scores do not distinguish depression from other conditions with overlapping symptoms (anxiety, trauma)
Common pitfalls
This section is available to Pro members. Upgrade to Pro
Applications
This section is available to Pro members. Upgrade to Pro
Frequently asked
What is the difference between BDI-I and BDI-II?
The BDI-II (1996 revision) reflects DSM-IV diagnostic criteria more closely, places greater emphasis on cognitive symptoms, and specifies a 2-week assessment window. The original BDI-I asked about lifetime depression without a defined timeframe.
Can BDI results diagnose depression?
No. The BDI is a severity measure and screening tool, not a diagnostic instrument. A formal diagnosis requires a structured clinical interview (e.g., SCID) combined with clinical judgment and DSM-5 criteria.
What cutoff scores indicate different severity levels?
Typical cutoffs are 0–9 (minimal), 10–18 (mild), 19–29 (moderate), and 30–63 (severe), though these vary by context and population.
How often should the BDI be administered during treatment?
Standard practice is weekly to bi-weekly during active psychotherapy, with less frequent assessment (monthly to quarterly) during maintenance or follow-up phases.
Sources
- 1.Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the Beck Depression Inventory-II. Psychological Corporation.ISBN 0158700194
- 2.Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4(6), 561–571.
You have read it. What now?
Cite this page
ScholarGate. (2026, June 3). Beck Depression Inventory. ScholarGate. https://scholargate.app/clinical-psychology/beck-depression-inventory